| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytokinetics, Incorporated (CYTK) have been net sellers, shedding 76,163 shares worth roughly $6.0M on balance. In the past 30 days, 0 insiders bought and 1 sold.
Not all activity pointed one way: 1 insider sold in the same window, though they still hold shares. Classified under Biotechnology (Health Care sector), CYTK's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 400.3K | $30.73M | - | |
| VP | 157.4K | $12.08M | -3,500 | |
| CFO | 100.8K | $7.74M | - | |
| Other | 87.3K | $6.70M | - | |
| VP | 58.6K | $4.49M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 10, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $50.64 | $369,639.00 | -3.0% | -14.3% | +19.3% | |
| Dec 2, 2024 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $50.76 | $253,800.00 | -1.2% | -15.3% | +25.4% | |
| Nov 26, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $50.16 | $366,181.00 | -3.1% | -7.5% | +31.0% | |
| Nov 25, 2024 | Wierenga Wendall59 | Director | Sale+OE | 742 | $50.00 | $37,100.00 | -2.9% | -4.2% | +34.4% | |
| Nov 18, 2024 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $50.55 | $252,750.00 | -1.2% | -12.6% | +27.4% | |
| Nov 12, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 6,342 | $58.48 | $370,880.16 | -2.7% | -24.9% | +17.4% | |
| Nov 1, 2024 | Blum Robert I50 | President &CEO | Sale+OE | 5,000 | $51.63 | $258,150.00 | -1.2% | -3.6% | +22.7% | |
| Oct 30, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $51.91 | $378,930.00 | -3.1% | -5.1% | +21.3% | |
| Oct 28, 2024 | Wierenga Wendall59 | Director | Sale+OE | 4,452 | $52.25 | $232,617.00 | -15.3% | -4.4% | +18.6% | |
| Oct 15, 2024 | Malik Fady Ibraham55 | EVP Research &Development | Sale+OE | 7,300 | $54.19 | $395,554.00 | -3.0% | -15.7% | +13.4% |